Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K6UQ
|
|||
Former ID |
DIB007533
|
|||
Drug Name |
HLA-A*2402-restricted KIF20A and VEGFR-1 epitope peptide vaccine
|
|||
Synonyms |
HLA-A*2402-restricted KIF20A and VEGFR-1 epitope peptide vaccine (pancreatic cancer, subcutaneous)
Click to Show/Hide
|
|||
Indication | Pancreatic cancer [ICD-11: 2C10] | Phase 1 | [1] | |
Company |
Juntendo University
|
References | Top | |||
---|---|---|---|---|
REF 1 | Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer. Int J Oncol. 2014 Mar;44(3):662-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.